Citation tools
"Response evaluation with 18F FDG PET CT in hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative (HR+/HER2−) advanced metastatic breast cancer (mBC) treated with cyclin-dependent kinase 4 and 6 (CDK4/6)inhibitors plus endocrine treatment.." Journal of Nuclear Medicine
62.supplement 1
(2021):
1104.
Web. 03 June. 2025.